Skip to content
healthcare.dev

IMKELDI

NDC 81927-201, imatinib oral, solution, from Shorla Oncology Inc.,.

Product NDC
81927-201
Status
Listed
Labeler
Shorla Oncology Inc.,
Dosage form
SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219097
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/81927-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • IMATINIB MESYLATE80 mg/mL

Pharmacologic classes

Bcr-Abl Tyrosine Kinase Inhibitors [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kinase Inhibitor [EPC]

Package NDCNDC-11Package
81927-201-0181927020101140 mL in 1 BOTTLE (81927-201-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/26658bb7-9ba1-a10e-e063-6394a90a172e

Use it

Look up 81927-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/81927-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 81927-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.